Literature DB >> 13819536

Factors determining pathogenicity of variants of ECHO 9 virus for newborn mice.

H J EGGERS, A B SABIN.   

Abstract

While some strains of ECHO 9 virus were found to be completely incapable of multiplying in newborn mice or even of being adsorbed by their tissues (e.g., the prototype Hill strain), other naturally occurring strains readily multiplied even after inoculation of as little as 3 TCD(50) of virus. With the multiplying strains, the infection remained clinically inapparent except after inoculation of very large doses, usually in the range of 10(5) to 10(7.5) TCD(50). Investigation of the question why such large doses were required to produce paralysis indicated that for paralysis to occur virus multiplication had to reach a level of 10(8) TCD(50) or more within 4 days after inoculation of mice less than 1 day old. The reason for this was found in the fact that at 5 to 6 days of age the mice lost their susceptibility to paralysis even when multiplication was capable of progressing to the indicated high level. Thus, speed of multiplication and extent of muscle involvement before the 5th day of life were the determining factors. Passage in tissue culture had no effect except to yield a larger dose for inoculation, while serial propagation in mice resulted in a gradual enrichment of virus particles capable of more rapid multiplication in mice and in a concurrent greater paralytogenic activity of smaller doses.

Entities:  

Keywords:  VIRUS DISEASES/experimental

Mesh:

Year:  1959        PMID: 13819536      PMCID: PMC2137040          DOI: 10.1084/jem.110.6.951

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  [Diseases caused by Echo-virus type 9; epidemiological, clinical and virological-serological study].

Authors:  T BAUMANN; M BARBEN; R MARTI; A HASSLER; U KRECH
Journal:  Schweiz Med Wochenschr       Date:  1957-03-30

2.  Association of mouse pathogenic strain of Echo virus type 9 with aseptic meningitis.

Authors:  D M MCLEAN; J L MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1957-04

3.  ECHO virus type 9 as the agent responsible for an important outbreak of aseptic meningitis in Belgium.

Authors:  E NIHOUL; L QUERSIN-THIRY; A WEYNANTS
Journal:  Am J Hyg       Date:  1957-07

4.  Echo virus type 9 (new member of Coxsackie group type A?) as a cause of epidemic meningitis.

Authors:  L QUERSIN-THIRY; E NIHOUL; F DEKKING
Journal:  Science       Date:  1957-04-19       Impact factor: 47.728

5.  Isolation of viruses related to Echo virus type 9 from outbreaks of aseptic meningitis.

Authors:  G P BOISSARD; L J STOKES; A D MACRAE; F O MACCALLUM
Journal:  Lancet       Date:  1957-03-09       Impact factor: 79.321

6.  [Epidemic of Coxsackie meningitis].

Authors:  I BROHL; K HELMSTAEDT; H LENNARTZ; G MAASS
Journal:  Z Arztl Fortbild (Jena)       Date:  1957-06-15

7.  Isolation of ECHO virus type 9 from cerebrospinal fluids.

Authors:  A GODTFREDSEN; H VON MAGNUS
Journal:  Dan Med Bull       Date:  1957-12

8.  Recovery of a virus from cases of an epidemic exanthem associated with meningitis.

Authors:  B SNELL; D A TYRRELL
Journal:  Lancet       Date:  1956-11-17       Impact factor: 79.321

9.  Characteristics of poliomyelitis and other enteric viruses recovered in tissue culture from healthy American children.

Authors:  M RAMOS-ALVAREZ; A B SABIN
Journal:  Proc Soc Exp Biol Med       Date:  1954-12

10.  Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture.

Authors:  M RAMOS-ALVAREZ; A B SABIN
Journal:  Am J Public Health Nations Health       Date:  1956-03
View more
  23 in total

1.  LABORATORY DIAGNOSIS OF ECHO TYPE 9 VIRUS INFECTION.

Authors:  E J BELL; J STOTT; C A ROSS
Journal:  Arch Gesamte Virusforsch       Date:  1964

Review 2.  CELLULAR SUSCEPTIBILITY TO ENTEROVIRUSES.

Authors:  C M KUNIN
Journal:  Bacteriol Rev       Date:  1964-12

3.  Properties of epidemic strains of ECHO type 9 virus and observations on the nature of human infection.

Authors:  R WIGAND; A B SABIN
Journal:  Arch Gesamte Virusforsch       Date:  1962

4.  Clinical, epidemiological, and virological aspects of echovirus type 9 infection in Sheffield, 1960.

Authors:  D HOBSON; J M HOSKINS; J HORNER; A H CLARKE; F B WOOD
Journal:  Br J Prev Soc Med       Date:  1962-04

5.  [Biological and pathogenetic features of Coxsackie strains isolated in tissue culture. 212 virus isolations during the years 1958/59].

Authors:  H LENNARTZ; O PALACIOS; W HOEPKEN
Journal:  Z Hyg Infektionskr       Date:  1961

6.  Biochemistry and pathogenicity of echovirus 9. III. Thermosensitive mutants of echovirus 9, strain Barty, with reduced pathogenicity for newborn mice.

Authors:  B Rosenwirth; D Ziegenhagen; H J Eggers
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

7.  Interaction between enteroviruses and human endothelial cells in vitro. Alterations in the physical properties of endothelial cell plasma membrane and adhesion of human granulocytes.

Authors:  C J Kirkpatrick; B D Bültmann; H Gruler
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

8.  Foot-and-mouth disease virus: selection by homogenized calf kidney adsorption and cell culture passage.

Authors:  C H Campbell
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

9.  The inactivation of enterovirus infectivity by the sulfhydryl reagent p-chloromercuribenzoate.

Authors:  P W CHOPPIN; L PHILIPSON
Journal:  J Exp Med       Date:  1961-04-01       Impact factor: 14.307

10.  Pathogenicity for suckling mice of Coxsackie viruses adapted to human amnion cells.

Authors:  F LEHMANN-GRUBE; J T SYVERTON
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.